PharmAla Biotech's MDMA focus and Recipe for Success in the Psychedelics Space
- Author
- Water Tower Research
- Published
- Wed 27 Mar 2024
- Episode Link
- None
Canada-based PharmAla Biotech's Founding CEO and President Nick Kadysh joins WTR's Tim Regan and Robert Sassoon to discuss PharmAla's focus on MDMA, the regulatory environment, and the company's recipe for success in the psychedelics space. Founded three years ago, the company reported annualized revenue of C$3 million and achieved a first-time profit for its most recent reported quarter.
